Amantadine reduces sepsis-induced brain injury via NLRP3/caspase-1 inflammasome activation

Articles in Press

Document Type : Original Article

Authors

1 Department of Anesthesiology and Reanimation, Suleyman Demirel University, Isparta, Türkiye

2 Department of Medical Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye

3 Department of Medical Genetics, University of Suleyman Demirel, Isparta, Türkiye

4 Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye

5 Department of Bioengineering, Institute of Science and Technology, Suleyman Demirel University Isparta, Türkiye

Abstract

Objective(s): Sepsis, a severe consequence of infection leading to organ failure, incites damage in frequently affected brain tissue through inflammation and oxidative stress. This study aimed to assess the effectiveness of amantadine, an N-methyl-D-aspartate (NMDA) receptor antagonist, in mitigating sepsis-induced brain damage.
Materials and Methods: Thirty-two Wistar albino male rats were allocated into four groups: control, LPS (lipopolysaccharide 5 mg/kg, intraperitoneal, single-dose), LPS + amantadine, and amantadine alone. Six hours post-LPS administration, rats were euthanized under anesthesia. The neutrophilic infiltration and necrosis reaction were assessed in lung tissues through histopathological analysis, while expressions of interferon-alpha (IFN-α), caspase-3 (Cas-3), and Tumor necrosis factor-alpha (TNF-α) were examined using the immunohistochemical method. Levels of biochemical total anti-oxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) were evaluated via the ELISA method. IL-1β, Cas-1, NLRP3, and IL-18 were evaluated via real-time qPCR.
Results: The LPS group exhibited histopathologically significant hyperemia, increased septal tissue thickness, hemorrhage, and inflammatory cell infiltrates, and increased IFN-α, Cas-3, TNF-α immunohistochemical expressions, and IL-1 beta, IL-18, NLRP3, and Cas-1, gene expressions compared to the control group. All these findings were significantly reversed with amantadine treatment.
Conclusion: The pathophysiology of brain damage due to systemic inflammation is complex. Our findings suggest that amantadine reduces neuronal injury in the brain by alleviating oxidative stress and inflammation. Notably, amantadine’s efficacy appears to extend beyond NMDA receptors, implicating involvement in alternative pathways, such as Cas-1 activation by the NLRP3 inflammasome.

Keywords

Main Subjects

References

1. Esposito S, De Simone G, Boccia G, De Caro F, Pagliano P. Sepsis and septic shock: New definitions, new diagnostic and therapeutic approaches. J Glob Antimicrob Resist
2017;10: 204-212.
2. Srzić I, Nesek AV, Tunjić Pejak D. Sepsıs defınıtıon: What’s new 
in the treatment guıdelınes. Acta Clin Croat 2022; 61: 67-72.
3. Gao Q, Hernandes MS. Sepsis-associated encephalopathy and blood-brain barrier dysfunction. Inflammation 2021;44: 2143-2150.
4. Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T. Septic-associated encephalopathy: A comprehensive review. Neurotherapeutics 2020; 17:  392-403.
5. Molnar L, Fülesdi B, Németh N, Molnár C. Sepsis-associated encephalopathy: A review of literature. Neurol India 2018; 66: 352-361.
6. Gadre SK, Shah M, Mireles CE, Patel B, Duggal A. Epidemiology and predictors of 30-day readmission in patients with sepsis. Chest 2019; 155: 483-490.
7. Löscher W, Gericke B. Novel intrinsic mechanisms of active drug extrusion at the blood-brain barrier: Potential targets for enhancing drug delivery to the brain? Pharmaceutics. 2020; 12:966-997.
8.    Jesus AA, Passaglia P, Santos BM, Rodrigues SI, Flores RA, Batalhão ME, et al. Chronic molecular hydrogen inhalation mitigates short and long-term memory loss in polymicrobial sepsis. Brain Res 2020; 1739: 146857.
9.    Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. The Lancet Neurology 2014; 13: 630-636.
10.    Jiménez-Jiménez FJ, Alonso-Navarro H, Arcía-Martín E, Agúndez JAG. Anti-inflammatory effects of amantadine and memantine: possible therapeutics for the treatment of covid-19? J Pers Med 2020;10:217-231.
11. Mohamed MS, El Sayed I, Zaki A, Abdelmonem S. Assessment of the effect of amantadine in patients with traumatic brain injury: A meta-analysis. J Trauma Acute Care Surg 2022; 92: 605-614.
12. Rahmani E, Lemelle TM, Samarbafzadeh E, Kablinger AS. Pharmacological treatment of agitation and/or aggression in patients with traumatic brain injury: A systematic review of reviews. J Head Trauma Rehabil 2021; 36: 262-283.
13. Gao Y, Ma L, Liang F, Zhang Y, Yang L, Liu X, et al. The use of amantadine in patients with unresponsive wakefulness syndrome after severe cerebral hemorrhage. Brain Inj 2020;34: 1084-1088.
14. Lin SP, Zhu L, Shi H, Ye S, Li Q, Yin X, et al. Puerarin prevents sepsis-associated encephalopathy by regulating the AKT1 pathway in microglia. Phytomedicine 2023;121:155119. 
15. Xu Y, Shen B, Pan X, Liu C, Wang Y, Chen X, et al. Palmatine ameliorated lipopolysaccharide-induced sepsis-associated encephalopathy mice by regulating the microbiota-gut-brain axis. Phytomedicine 2024;124:155307. 
16. Zhou Z, Yang Y, Wei Y, Xie Y. Remimazolam attenuates lps-derived cognitive dysfunction via subdiaphragmatic vagus nerve target α7nachr-mediated nrf2/ho-1 signal pathway. Neurochem Res 2024; 49:1306-1321.  
17. Sahin F, Tuna AT, Unal Y, Arslan M, Sezen SC, Gozukara SI et al. Effects of amantadine on liver and lung tissue in hepatic ıschemia reperfusion ınjury in rats. Gazi Med J 2023; 34:10-15.    
18. Erel O. A novel automated direct measurement method for total anti-oxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
19. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38: 1103-1111.
20. Robba C, Crippa IA, Taccone FS. Septic encephalopathy. Curr Neurol Neurosci Rep 2018; 18: 82.
21. Peng X, Luo Z, He S, Zhang L, Li Y. Blood-brain barrier disruption by lipopolysaccharide and sepsis-associated encephalopathy. Front Cell Infect Microbiol 2021; 11: 768108.
22. Salmani H, Hosseini M, Nabi MM, Samadi-Noshahr Z, Baghcheghi Y, Sadeghi M. Exacerbated immune response of the brain to peripheral immune challenge in post-septic mice. Brain Res Bull 2022; 185: 74-85.
23. Anderson ST, Commins S, Moynagh PN, Coogan AN. Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse. Brain Behav  Immun 2015; 43: 98-109.
24. Catarina AV, Branchini G, Bettoni L, De Oliveira JR, Nunes FB. Sepsis-associated encephalopathy: From pathophysiology to progress in experimental studies. Mol Neurobiol 2021; 58: 2770-2779.
25. Ren C, Yao RQ, Zhang H, Feng YW, Yao YM. Sepsis-associated encephalopathy: A vicious cycle of immunosuppression. J Neuroinflammation 2020; 17: 14-28.
26. Sánchez-Rodríguez MA, Mendoza-Núñez VM. Oxidative stress ındexes for diagnosis of health or disease in humans. Oxid Med Cell Longev 2019; 25: 4128152. 
27. Effah CY, Ding X, Drokow EK, Li X, Tong R, Sun T. Bacteria-derived extracellular vesicles: Endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis. Front Immunol 2024; 15: 1296061.
28. El-Shitany NA, Eid BG. Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways. Biomed Pharmacother 2019; 120: 109567. 
29. Taheri G, Sardari M, Hermann DM, Sepehri H. N-methyl-d-aspartate receptors antagonist prevents secondary ischemic brain injury associated with lipopolysaccharide-induced sepsis-like state presumably via immunomodulatory actions. Front Cell Neurosci 2022; 16: 881088.
30. An J, Chen B, Kang X, Zhang R, Guo Y, Zhao J, et al. Neuroprotective effects of natural compounds on LPS-induced inflammatory responses in microglia. Am J Transl Res 2020; 12: 2353-2378.
31. Caban M, Lewandowska U. Polyphenols and the potential mechanisms of their therapeutic benefits against inflammatory bowel diseases. J  Func Foods 2022; 95: 105181.
32. Mao K, Chen S, Chen M, Ma Y, Wang Y, Huang B, et al. Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell res 2013; 23: 201-212.
33. Mina F, Comim CM, Dominguini D, Cassol OJJr, Dall Igna DM, Ferreira GK, et al. Il1-β involvement in cognitive impairment after sepsis. Mol Neurobiol 2014; 49 :1069-1076.
34. Imamura Y, Wang H, Matsumoto N, Muroya T, Shimazaki J, Ogura H, et al. Interleukin-1β causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience 2011; 187: 63-69.
35. Xing W, Huang P, Lu Y, Zeng W, Zuo Z. Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2. J Mol. Med 2018; 96: 391-402.
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 19 January 2025

Files

Share

How to cite

Statistics